Al-Jumayli M - Search Results

1

Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma.

Park R, Eshrat F, Al-Jumayli M, Saeed A, Saeed A. Park R, et al. Vaccines (Basel). 2020 Aug 8;8(3):447. doi: 10.3390/vaccines8030447. Vaccines (Basel). 2020. PMID: 32784389 Free PMC article. Review.

2

Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma.

Saeed A, Park R, Al-Jumayli M, Al-Rajabi R, Sun W. Saeed A, et al. Clin Colorectal Cancer. 2019 Jun;18(2):81-90. doi: 10.1016/j.clcc.2019.02.005. Epub 2019 Feb 27. Clin Colorectal Cancer. 2019. PMID: 30905548 Review.

3

Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study.

Saeed A, Hildebrand H, Park R, Al-Jumayli M, Abbasi S, Melancon T, Saeed A, Al-Rajabi R, Kasi A, Baranda J, Williamson S, Sun W. Saeed A, et al. J Clin Med. 2020 Aug 19;9(9):2682. doi: 10.3390/jcm9092682. J Clin Med. 2020. PMID: 32824968 Free PMC article.

4

Exceptional response to Erlotinib monotherapy in EGFR Exon 19-deleted, KRAS wild-type, Chemo-refractory advanced pancreatic adenocarcinoma.

Park R, Al-Jumayli M, Miller K, Saeed A, Saeed A. Park R, et al. Cancer Treat Res Commun. 2021;27:100342. doi: 10.1016/j.ctarc.2021.100342. Epub 2021 Feb 17. Cancer Treat Res Commun. 2021. PMID: 33611092 Free article.

5

Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review.

Kasi A, Al-Jumayli M, Park R, Baranda J, Sun W. Kasi A, et al. J Pancreat Cancer. 2020 Dec 4;6(1):107-115. doi: 10.1089/pancan.2020.0010. eCollection 2020. J Pancreat Cancer. 2020. PMID: 33376937 Free PMC article. Review.

6

Pre-operative Carboplatin/Paclitaxel Versus 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer.

Al-Jumayli M, Choucair K, Al-Obaidi A, Park R, Bansal A, Baranda J, Sun W, Saeed A. Al-Jumayli M, et al. Anticancer Res. 2022 Jan;42(1):59-66. doi: 10.21873/anticanres.15457. Anticancer Res. 2022. PMID: 34969709

7

Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience.

Al-Jumayli M, Batool A, Middiniti A, Saeed A, Sun W, Al-Rajabi R, Baranda J, Kumer S, Schmitt T, Chidharla A, Kasi A. Al-Jumayli M, et al. J Oncol. 2019 May 2;2019:3293509. doi: 10.1155/2019/3293509. eCollection 2019. J Oncol. 2019. PMID: 31186632 Free PMC article.

8

Clinical Outcomes of Different Treatment Modalities in Anaplastic Thyroid Cancer: A Single Center Experience.

Al-Jumayli M, Kawsar HI, Neupane P. Al-Jumayli M, et al. Am J Ther. 2022 Nov-Dec 01;29(6):e714-e716. doi: 10.1097/MJT.0000000000001254. Epub 2020 Sep 1. Am J Ther. 2022. PMID: 32889810 No abstract available.

9

Predictors of Toxicity Among Older Adults with Cancer.

Extermann M, Chetty IJ, Brown SL, Al-Jumayli M, Movsas B. Extermann M, et al. Among authors: al jumayli m. Semin Radiat Oncol. 2022 Apr;32(2):179-185. doi: 10.1016/j.semradonc.2021.11.004. Semin Radiat Oncol. 2022. PMID: 35307121 Review.

10

The Biological Process of Aging and the Impact of Ionizing Radiation.

Al-Jumayli M, Brown SL, Chetty IJ, Extermann M, Movsas B. Al-Jumayli M, et al. Semin Radiat Oncol. 2022 Apr;32(2):172-178. doi: 10.1016/j.semradonc.2021.11.011. Semin Radiat Oncol. 2022. PMID: 35307120 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page